Apollomics(APLMW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APLMW Apollomics

休市中 12-27 16:00:00 EST

0.0129

+0.0010

+8.40%

最高0.0129	最低0.0100	成交量6,898
今开0.0101	昨收0.0119	日振幅24.37%
总市值0.00	流通市值0.00	总股本0.00
成交额74.82	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"APLMW","market":"US","secType":"STK","nameCN":"Apollomics","latestPrice":0.0129,"timestamp":1735333200000,"preClose":0.0119,"halted":0,"volume":6898,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":0.001,"latestTime":"12-27 16:00:00 EST","open":0.0101,"high":0.0129,"low":0.01,"amount":74.81715,"amplitude":0.243697,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0119,"volumeRatio":0.380004850983932},"requestUrl":"/m/hq/s/APLMW/wiki","defaultTab":"wiki","newsList":[{"id":"2493227424","title":"Apollomics 公布 Uproleselan 在中国治疗复发或难治性急性髓系白血病患者的第 3 期衔接性试验的主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2493227424","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493227424?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:13","pubTimestamp":1734718380,"startTime":"0","endTime":"0","summary":"该试验没有显示出对 uproleselan 有利的结果。Uproleselan 组严重不良事件的发生率为 43%，单独化疗组则为 39%。Uproleselan 组最常见的严重不良事件是血小板数量减少、感染性肺炎和败血症。在 2024 年 8 月，Apollomics 宣布降低与 uproleselan 项目预付款相关无形资产的账面价值。Apollomics 即将结束临床试验，预计 uproleselan 项目在未来的开销将低于 50 万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000788/0/zh-hant/Apollomics-%E5%85%AC%E5%B8%83-Uproleselan-%E5%9C%A8%E4%B8%AD%E5%9C%8B%E6%B2%BB%E7%99%82%E5%BE%A9%E7%99%BC%E6%88%96%E9%9B%A3%E6%B2%BB%E6%80%A7%E6%80%A5%E6%80%A7%E9%AB%93%E7%B3%BB%E7%99%BD%E8%A1%80%E7%97%85%E6%82%A3%E8%80%85%E7%9A%84%E7%AC%AC-3-%E6%9C%9F%E9%8A%9C%E6%8E%A5%E6%80%A7%E8%A9%A6%E9%A9%97%E7%9A%84%E4%B8%BB%E8%A6%81%E7%B5%90%E6%9E%9C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW"],"gpt_icon":0},{"id":"2492446922","title":"BUZZ-血癌药物试验失败，Apollomics业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2492446922","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492446922?lang=zh_cn&edition=full","pubTime":"2024-12-20 21:59","pubTimestamp":1734703163,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    12月20日 - ** 生物技术公司Apollomics  股价盘前下跌约30%至6.63美元 ** 该公司称，在一项晚期试验中，其试验性血癌疗法与化疗联合使用未能显示出 (link) 延长生存期对单独化疗有利的效果** Apollomics公司正在复发或难治性急性髓性白血病患者中测试这种名为uproleselan的疗法(AML)** 急性髓性白血病是一种始于骨髓并影响白细胞的血癌。** 截至上次收盘，该公司股价年累计下跌约 90","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APLMW","APLM"],"gpt_icon":0},{"id":"2459903343","title":"BUZZ-Apollomics公司因癌症治疗研究的初步数据良好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2459903343","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459903343?lang=zh_cn&edition=full","pubTime":"2024-08-13 20:51","pubTimestamp":1723553483,"startTime":"0","endTime":"0","summary":"    8月13日 - ** 药物开发商Apollomics公司  的股价盘前翻了一番多，达到35美分** 该公司宣布其试验性癌症疗法 vebreltinib 的中期研究初步数据良好** 公司称，该疗法在14名患有一种名为非中枢神经系统MET融合的实体瘤的癌症患者中显示出43%的客观反应率 ** ORR是指在预定时间内肿瘤缩小的患者比例。** 公司正在开发 vebreltinib 作为单药治疗多种肿瘤类型的癌症疗法** 截至上一交易日收盘，股价累计下跌 83.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW","BK4139","APLM","BUZZ"],"gpt_icon":0},{"id":"2452288849","title":"Apollomics被授予180天延期以符合纳斯达克的最低买盘价格要求。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452288849","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452288849?lang=zh_cn&edition=full","pubTime":"2024-07-17 04:47","pubTimestamp":1721162877,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":[".IXIC","03086","QID","ARTL","APLMW","BK4007","NDX","BK1147","MNQmain","PSQ","TQQQ","NQmain","159632","SQQQ","QLD","QQQ"],"gpt_icon":0},{"id":"2448101846","title":"Apollomics宣布更新战略重心和领导团队变化。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448101846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448101846?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:00","pubTimestamp":1720008001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["APLMW"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":-0.1886},{"period":"3month","weight":0.29},{"period":"6month","weight":-0.0786},{"period":"1year","weight":-0.6692},{"period":"ytd","weight":-0.484}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"NASDAQ","name":"Apollomics","nameEN":"Apollomics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apollomics(APLMW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apollomics(APLMW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apollomics,APLMW,Apollomics股票,Apollomics股票老虎,Apollomics股票老虎国际,Apollomics行情,Apollomics股票行情,Apollomics股价,Apollomics股市,Apollomics股票价格,Apollomics股票交易,Apollomics股票购买,Apollomics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apollomics(APLMW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apollomics(APLMW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}